TP53 and malignant colon neoplasm: In non-HD models, lithium has demonstrated mixed effects, including upregulating p53 in bovine aortic endothelial cells [131] and degrading p53 in human HCT116 colon cancer cells [132] and attenuating p53 levels in human SH-SY5Y cells [133].